Dan Schwartz is Professor Emeritus at UCSF.
He was recently appointed as Physician-in-Residence at the Merkin Institute for Translational Research, Caltech. He is the director of the Retina Service at the San Francisco VAMC. Over the past 25 years, Dan has collaborated with several faculty at Caltech working to develop various medical devices and more recently, therapeutic agents. With Bob Grubbs (Chemistry), Julie Kornfield (chemical engineering), and post-docs Chris Sandstedt and Jagdish Jethmalani, Dan collaborated to develop the LightAdjustable Lens (LAL), the first intraocular lens for cataract surgery that can be adjusted non-invasively using light. The LAL is now FDA approved and is being commercialized by RxSight (rxsight.com) in the US. With Scott Fraser (now at USC), Bob Grubbs, and post-doc Jeff Fingler, Dan collaborated to develop optical coherence tomography angiography (OCTA), the first non-invasive means of imaging the retinal vasculature. This technology is now widely used internationally in the care of patients with macular degeneration, diabetic retinopathy, and other retinovascular diseases.